Filariasis News and Research RSS Feed - Filariasis News and Research

Filariasis (Philariasis) is a parasitic and infectious tropical disease, that is caused by thread-like filarial nematode worms in the superfamily Filarioidea, also known as "filariae". There are 9 known filarial nematodes which use humans as the definitive host.
Further Reading
Researchers developing new medication to tackle river blindness and elephantiasis

Researchers developing new medication to tackle river blindness and elephantiasis

Researchers are developing new drug treatments to tackle river blindness and elephantiasis, which affect up to 150 million people across the world. [More]
LSTM and University of Liverpool receive GHIT Fund to target lymphatic filariasis and onchocerciasis

LSTM and University of Liverpool receive GHIT Fund to target lymphatic filariasis and onchocerciasis

The Liverpool School of Tropical Medicine (LSTM) together with colleagues at the Department of Chemistry (University of Liverpool (UoL)) and Japanese pharmaceutical company Eisai are pleased to announce that they have been awarded a Global Health Innovative Technology (GHIT) Fund to develop new drugs to target lymphatic filariasis and onchocerciasis. [More]
Indonesia's commitment, investment in eliminating NTDs could lift millions of people out of poverty

Indonesia's commitment, investment in eliminating NTDs could lift millions of people out of poverty

The control and elimination of neglected tropical diseases (NTDs) is one of the most cost-effective ways Indonesia can sustain economic growth and reduce inequality, said scientists today in an analysis published in PLOS Neglected Tropical Diseases. [More]
Viewpoints: The battle over one woman's medical story; why Mass. didn't see a wave of cancellations; politicians' love of anecdotes

Viewpoints: The battle over one woman's medical story; why Mass. didn't see a wave of cancellations; politicians' love of anecdotes

Edie Littlefield Sundby may not have thought she'd ignite a national debate when the stage-4 cancer survivor asked us to publish her Monday op-ed on losing her oncologist due to the Affordable Care Act. But she certainly has, and it's important to understand why. Mrs. Sundby and millions like her must be denied their medical choices if ObamaCare is going to work as its liberal planners intend (11/6). [More]
Eisai supplies diethylcarbamazine citrate 100 mg tablets to WHO

Eisai supplies diethylcarbamazine citrate 100 mg tablets to WHO

Eisai Co., Ltd. announced today that it has begun the free supply of diethylcarbamazine citrate (DEC) 100 mg tablets produced at its Vizag Plant in India to the World Health Organization in line with its commitment to help WHO in its global effort to eliminate lymphatic filariasis in targeted developing and emerging countries. [More]
LSTM professor awarded The Manson Medal for outstanding contribution in field of tropical medicine

LSTM professor awarded The Manson Medal for outstanding contribution in field of tropical medicine

The Liverpool School of Tropical Medicine (LSTM) is delighted that Emeritus Professor and Senior Professional Fellow, David Molyneux, has been awarded The Manson Medal, the Royal Society of Tropical Medicine and Hygiene's highest mark of distinction. [More]
Low-cost intervention reduces transmission of lymphatic filariasis to undetectable levels

Low-cost intervention reduces transmission of lymphatic filariasis to undetectable levels

An international team of scientists have demonstrated that a simple, low-cost intervention holds the potential to eradicate a debilitating tropical disease that threatens nearly 1.4 billion people in more than six dozen countries. [More]
DFID awards 5-year grant to DNDi to advance research and development for neglected diseases

DFID awards 5-year grant to DNDi to advance research and development for neglected diseases

The UK Department for International Development (DFID) has announced its renewed support to the Drugs for Neglected Diseases initiative (DNDi), allocating a total of - 30 million (- 35 million) over the coming five years (2013-2018) to DNDi's Research & Development (R&D) portfolio to fight neglected diseases. [More]
Human filariasis research: an interview with Professor Mark Taylor, Liverpool School of Tropical Medicine

Human filariasis research: an interview with Professor Mark Taylor, Liverpool School of Tropical Medicine

Filariasis refers to a group of diseases caused by parasitic worms, which are transmitted by blood feeding insects. Two species infect the lymphatic and blood systems causing lymphatic filariasis, which in some people can lead to gross swelling of the limbs and 'elephantiasis'. [More]
UC Riverside researchers develop easy-to-wear patch that makes humans invisible to mosquitoes

UC Riverside researchers develop easy-to-wear patch that makes humans invisible to mosquitoes

​Technology that hampers mosquitoes' host-seeking behavior, identified at the University of California, Riverside in 2011, has led to the development of the world's first product that blocks mosquitoes' ability to efficiently detect carbon dioxide, their primary method of tracking human blood meals. [More]
Liverpool School of Tropical Medicine receives US$ 10 million to continue research against human filariasis

Liverpool School of Tropical Medicine receives US$ 10 million to continue research against human filariasis

Liverpool School of Tropical Medicine (LSTM) has received US$ 10 million from the Bill & Melinda Gates Foundation to continue their breakthrough drug discovery and development research against human filariasis - parasitic worm infections which cause river blindness and elephantiasis, some of the world’s most debilitating diseases affecting up to 150 million people in 83 countries throughout the tropics. [More]
Sustained engagement, partnership needed to implement new treatments for neglected diseases

Sustained engagement, partnership needed to implement new treatments for neglected diseases

Days after two landmark resolutions were adopted at the World Health Assembly - on neglected tropical diseases and on research and development, financing and coordination for the health needs of developing countries - over 400 scientists, representatives and ministers of health, ambassadors, national control programme representatives, African regulators, health workers, public health experts, and activists from 21 African countries and 10 others from around the world gather in Nairobi to take stock of health innovation for neglected diseases in Africa over the past decade. [More]

Queen's University Belfast scientists awarded research grants to tackle tropical diseases

Queen's University Belfast has been announced as a Grand Challenges Explorations winner, an initiative founded by the Bill & Melinda Gates Foundation. Scientists at the University's Institute for Global Food Security have been awarded grants to pursue two Innovative global health and development research projects aimed at tackling tropical diseases. [More]
New diagnostic test for lymphatic filariasis

New diagnostic test for lymphatic filariasis

A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field study in Liberia, in West Africa, where the infection is endemic. [More]
Three steps to eliminating NTDs

Three steps to eliminating NTDs

In a post on the PLoS "Speaking of Medicine" blog, PLoS Neglected Tropical Diseases (NTDs) editor-in-chief Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, reviews progress being made toward the elimination of NTDs through mass drug administration and other efforts. [More]

VOA News reports on pilot program against lymphatic filariasis in Nigeria

VOA News reports on "a new public health strategy, tested in Nigeria," which is "raising hopes" that the tropical disease known as lymphatic filariasis, or elephantiasis, can be eliminated. [More]
Anacor signs research agreement to discover drug candidates to treat neglected diseases

Anacor signs research agreement to discover drug candidates to treat neglected diseases

Anacor Pharmaceuticals today announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two filarial worm diseases (onchocerciasis, or river blindness, and lymphatic filariasis, commonly known as elephantiasis) and tuberculosis. [More]
New Pope will need to consider burden of NTDs

New Pope will need to consider burden of NTDs

"Almost certainly, in its deliberations [to select a new Pope,] the conclave of cardinals will consider a number of difficult and well-publicized problems now facing the Catholic Church," Peter Hotez, co-editor in chief of PLoS Neglected Tropical Diseases, writes in the journal's "Speaking of Medicine" blog. [More]
Disease eradication efforts set sights on polio, Guinea worm

Disease eradication efforts set sights on polio, Guinea worm

"It's not a race, exactly, but there's an intriguing uncertainty about whether a former U.S. president or a software magnate will cause the next deliberate extinction of a species in the wild. Will Jimmy Carter eradicate Guinea worm before Bill Gates eradicates polio?" Wall Street Journal commentator Matt Ridley asks in his "Mind & Matter" column. [More]
Lancet commentary cautiously optimistic about public health system in Haiti

Lancet commentary cautiously optimistic about public health system in Haiti

In this Lancet commentary, John Vertefeuille, Scott Dowell, Jean Domercant and Jordan Tappero of the Centers for Disease Control and Prevention (CDC) examine the state of the public health system in Haiti three years after a 7.0 earthquake struck the country, writing, "Haiti is starting to show that its health services have expanded far beyond those in place before the earthquake occurred." [More]